参考文献/References:
[1].何权瀛,王莞尔.阻塞性睡眠呼吸暂停低通气综合征诊治指南（基层版）[J].中国呼吸与危重监护杂志,2015,14(4):398-405.
[2].Taranto ML,Kasai T.The upper airway in sleep-disordered breathing:UA in SDB[J]. Minerva Med,2014,105(1):25-40.
[3].Punjabi NM.The epidemiology of adult obstructive sleep apnea[J].Proc Am Thorac Soc,2011,5(2):136-143.
[4].Certal VF, Zaghi S, Riaz M, et al. Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea:a systematic review and meta-analysis[J]. Laryngoscope,2015,125(5):1254-1264.
[5].Somers VK,White DP,Amin R,et al.Sleep Apnea and Cardiovascular Disease:An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee,Council on Cardiovascular Nursing[J].J Am Coll Cardiol,2008,52(8):686-717.
[6].Noda A,Okada T,Yasuma F,et al.Cardiac hypertrophy in obstructive sleep apnea syndrome[J].Chest,1995,107(2):1538-1544.
[7].Marin JM,Carrizo SJ,Vicente E,et al. Long- term cardiovascular outcomes in men with obstructive sleep apnoea hypopnoea with or without treatment with continuous positive airway pressure:an observational study[J].Lancet,2005, 365(9464):1046-1053.
[8].Bacharova L,Triantafyllou E,Vazaios C,et al.The effect of obstructive sleep apnea on QRS complex morphology[J].J Electrocardiol,2015,48(2):164-170.
[9].曾勇,张稳,刘丹,等.高血压病左心室肥厚形成影响因素的研究进展[J].中国循环杂志,2013,28(6):477-479.
[10].Song YJ,Kwon JH,Kim JY,et al.The platelet-to-lymphocyte ratio reflects the severity of obstructive sleep apnea syndrome and on current hypertension[J]. Clin Hypertens,2015,22(1):1-8.
[11].Javaheri S, Barbe F, Campos-Rodriguez F, et al.Sleep apnea:types,mechanisms,and clinical cardiovascular consequences[J].J Am Coll Cardiol,2017,69(7):841-858.
[12].Lavie L,Vishnevsky A,Lavie P.Evidence for lipid peroxidation in obstructive sleep apnea[J].Sleep,2004,27(1):123-128.
[13].Jouett NP,Watenpaugh DE,Dunlap ME,et al.Interactive effects of hypoxia,hypercapnia and lung volume on sympathetic nerve activity in humans[J].Exp Physiol,2015,100(9):1018-1029.
[14].Toledo C,Andrade DC,Lucero C,et al.Contribution of peripheral and central chemoreceptors to sympatho-excitation in heart failure[J].J Physiol,2017, 595(1):43-51.
[15].Kasiakogias A,Tsioufis C,Thomopoulos C,et al.A hypertensive response to exercise is prominent in patients with obstructive sleep apnea and hypertension: a controlled study[J].Clin Hypertens,2013,15(7):497-502.
[16].Corlateanu A,Botnaru V,Sircu V,et al.Obstructive sleep apnea and type 2 diabetes:dual interaction[J].Curr Respir Med Rev,2015,11(4):292-298.
[17].Yvan-Charvet L,Quignard-Boulange A.Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity[J]. Kidney Int,2011,79(2):162-168.
[18].Kloet AD,Krause E.The renin angiotensin system and the metabolic syndrome[J]. Open Hypertens J,2010,99(5):525-534.
[19].Sanchezdela-Torre M,Campos-Rodriguez F,Barbe F.Obstructive sleep apnoea and cardiovascular disease[J].Lancet Respir Med,2013,1(1):61-72.
[20].Feres MC,Cintra FD,Rizzi CF,et al.Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension[J].PLoS One,2013,9(6):398-407.
[21].Zhang W,Sun Y,Li T,et al.The effect of obstructive sleep apnea-hypopnea syndrome on acute myocardial infarction[J].Bratisl Lek Listy,2012,113(9): 565-568.
[22].Meier-Ewert HK,Ridker PM,Rifai N,et al.Effect of sleep loss on C-reactive protein,an inflammatory markers of cardiovascular risk[J].J Am Coll Cardiol, 2004,43(4):678-83.
[23].Phillips BG,Hisel TM,Kato M,et al.Recent weight gain in patients with newly diagnosed obstructive sleep apnea[J].J Hypertens,1999,17(9):1297-1300.
[24].Tentolouris N,Liatis S,Katsilambros N.Sympathetic system activity in obesity and metabolic syndrome[J].Ann N Y Acad Sci,2010,1083(stress):129-152.
[25].Tatsumi K,Kasahara Y,Kurosu K,et al.Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome[J].Chest,2005,127(3): 716-721.
[26].Ip MSM,Lam KSL,Ho CM,et al.Serum leptin and vascular risk factors in obstructive sleep apnea[J].Chest,2000,118(3):580-586.
[27].林婧,吴佳慧,桂鸣.高血压合并阻塞性睡眠呼吸暂停综合征患者的临床特点及动态血压分析[J].江苏医药,2016,42(18):2036-2038.
[28].Kushida CA,Littner MR,Morgenthaler T,et al.Practice parameters for the indications for polysomnography and related procedures:an update for 2005[J]. Sleep,2005,28(4):499-523.
[29].Colish J,Walker J,Elmayergi N,et al.Obstructive sleep apnea:effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers,echocardiography,and cardiac MRI[J].Chest,2012,141(3): 674-681.
[30].Metta RV,Zaka A,Lee VC,et al.Continuous positive airway pressure adherence in patients with obstructive sleep apnea＆symptomatic BPH[J].Lung,2017,195(2): 255-261.
[31].Gagnadoux F,Jouvenot M,Meslier N,et al.Therapeutic alternatives to continuous positive airway pressure for obstructive sleep apnea-hypopnea syndrome[J]. Presse Med,2017,46(4):432-437.
[32].Camposrodriguez F,Martinezalonso M,Sanchezdelatorre M,et al.Long-term adherence to continuous positive airway pressure therapy in non-sleepy sleep apnea patients[J].Sleep Med,2016,17(1):1-6.
[33].周颖倩,叶京英.阻塞性睡眠呼吸暂停低通气综合征的发病机制及相应的个体化治疗策略[J].中华耳鼻咽喉头颈外科杂志,2016,51(11):877-880.
[34].Galicia-Castillo MC.In reply:opioid therapy and sleep apnea[J].Cleve Clin J Med,2017,84(2):94.
[35].Heiser C,Maurer JT,Hofauer B,et al.Outcomes of upper airway stimulation for obstructive sleep apnea in a multicenter German postmarket study[J]. Otolaryngol Head Neck Surg,2017,156(2):378-384.
[36].Verma RK,Jai RJ,Goyal M,et al.Oropharyngeal exercises in the treatment of obstructive sleep apnoea:our experience[J].Sleep And Breathing,2016,20(4): 1193-1201.
[37].[37]Warchol-Celinska E,Prejbisz A,Kadziela J,et al.Renal denervation in resistant hypertension and obstructive sleep apnea randomized proof-of-concept phase II trial[J].Hypertension,2018,72(2):381-390.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(5):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(5):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(5):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(5):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(5):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(5):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(5):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(5):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[9]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(5):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
[10]付士辉李玉龙骆雷鸣沈明志田进文邓珏琳.高血压基础研究现状与进展[J].心血管病学进展,2019,(9):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]
FU ShihuiLI YulongLUO LeimingSHEN MingzhiTIAN JinwenDENG Juelin.Status and Progress of Basic Researches about Hypertension[J].Advances in Cardiovascular Diseases,2019,(5):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]